GSK boosts respiratory portfolio with $1.4 bln Aiolos Bio deal

Posted on by
GSK boosts respiratory portfolio with $1.4 bln Aiolos Bio deal

Jan 9 (Reuters) – GSK (GSK.L) on Tuesday said it would acquire asthma drug maker Aiolos Bio in a deal worth up to $1.4 billion, as the British drugmaker boosts its growing respiratory diseases portfolio. Founded in 2023, Aiolos is focused on developing …
See Original Article

Watch Robeco's Chow: Greater Allocation To F.I. This Year – Bloomberg

This Year. Bloomberg Markets · TV Shows. January 7th, 2024, 8:35 PM PST.
See Original Article

Watch Optimal Capital Advisors' Stacy on US Markets – Bloomberg

Optimal Capital Advisors' Stacy on US Markets. Bloomberg Daybreak: Australia · TV Shows. January 7th, 2024, 9:05 PM PST.
See Original Article

COP28: Green finance skills and consistent accounting approaches needed to help …

Entrepreneurial purpose-driven businesses can work together with impact investors and accountants to enable more investment in support of climate
See Original Article

TV drama puts pressure on politicians over Post Office scandal – Tortoise Media

Some numbers to conjure with: 700, 60 and four. The first is the number of UK Post Office operators convicted of fraud, theft and false accounting
See Original Article

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.